444 related articles for article (PubMed ID: 24050857)
1. Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis.
Harrison RW; Hasselblad V; Mehta RH; Levin R; Harrington RA; Alexander JH
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1224-32. PubMed ID: 24050857
[TBL] [Abstract][Full Text] [Related]
2. Effect of levosimendan on prognosis in adult patients undergoing cardiac surgery: a meta-analysis of randomized controlled trials.
Chen QH; Zheng RQ; Lin H; Shao J; Yu JQ; Wang HL
Crit Care; 2017 Oct; 21(1):253. PubMed ID: 29041948
[TBL] [Abstract][Full Text] [Related]
3. Levosimendan reduces cardiac troponin release after cardiac surgery: a meta-analysis of randomized controlled studies.
Zangrillo A; Biondi-Zoccai G; Mizzi A; Bruno G; Bignami E; Gerli C; De Santis V; Tritapepe L; Landoni G
J Cardiothorac Vasc Anesth; 2009 Aug; 23(4):474-8. PubMed ID: 19217315
[TBL] [Abstract][Full Text] [Related]
4. Reducing mortality in cardiac surgery with levosimendan: a meta-analysis of randomized controlled trials.
Landoni G; Mizzi A; Biondi-Zoccai G; Bruno G; Bignami E; Corno L; Zambon M; Gerli C; Zangrillo A
J Cardiothorac Vasc Anesth; 2010 Feb; 24(1):51-7. PubMed ID: 19700350
[TBL] [Abstract][Full Text] [Related]
5. Perioperative levosimendan therapy is associated with a lower incidence of acute kidney injury after cardiac surgery: a meta-analysis.
Niu ZZ; Wu SM; Sun WY; Hou WM; Chi YF
J Cardiovasc Pharmacol; 2014 Feb; 63(2):107-12. PubMed ID: 24126568
[TBL] [Abstract][Full Text] [Related]
6. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery: An Update Meta-Analysis and Trial Sequential Analysis.
Wang B; He X; Gong Y; Cheng B
Biomed Res Int; 2018; 2018():7563083. PubMed ID: 29854789
[TBL] [Abstract][Full Text] [Related]
7. Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
Cholley B; Caruba T; Grosjean S; Amour J; Ouattara A; Villacorta J; Miguet B; Guinet P; Lévy F; Squara P; Aït Hamou N; Carillion A; Boyer J; Boughenou MF; Rosier S; Robin E; Radutoiu M; Durand M; Guidon C; Desebbe O; Charles-Nelson A; Menasché P; Rozec B; Girard C; Fellahi JL; Pirracchio R; Chatellier G;
JAMA; 2017 Aug; 318(6):548-556. PubMed ID: 28787507
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.
Hummel J; Rücker G; Stiller B
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011312. PubMed ID: 28262914
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan Reduces Mortality in Adults with Left Ventricular Dysfunction Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis.
Lim JY; Deo SV; Rababa'h A; Altarabsheh SE; Cho YH; Hang D; McGraw M; Avery EG; Markowitz AH; Park SJ
J Card Surg; 2015 Jul; 30(7):547-54. PubMed ID: 25989324
[TBL] [Abstract][Full Text] [Related]
10. Impact of prophylactic administration of Levosimendan on short-term and long-term outcome in high-risk patients with severely reduced left-ventricular ejection fraction undergoing cardiac surgery - a retrospective analysis.
Grieshaber P; Lipp S; Arnold A; Görlach G; Wollbrück M; Roth P; Niemann B; Wilhelm J; Böning A
J Cardiothorac Surg; 2016 Dec; 11(1):162. PubMed ID: 27906091
[TBL] [Abstract][Full Text] [Related]
11. Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies.
Landoni G; Biondi-Zoccai G; Greco M; Greco T; Bignami E; Morelli A; Guarracino F; Zangrillo A
Crit Care Med; 2012 Feb; 40(2):634-46. PubMed ID: 21963578
[TBL] [Abstract][Full Text] [Related]
12. Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial.
Mehta RH; Van Diepen S; Meza J; Bokesch P; Leimberger JD; Tourt-Uhlig S; Swartz M; Parrotta J; Jankowich R; Hay D; Harrison RW; Fremes S; Goodman SG; Luber J; Toller W; Heringlake M; Anstrom KJ; Levy JH; Harrington RA; Alexander JH;
Am Heart J; 2016 Dec; 182():62-71. PubMed ID: 27914501
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis.
Sanfilippo F; Knight JB; Scolletta S; Santonocito C; Pastore F; Lorini FL; Tritapepe L; Morelli A; Arcadipane A
Crit Care; 2017 Oct; 21(1):252. PubMed ID: 29047417
[TBL] [Abstract][Full Text] [Related]
14. Levosimendan improves renal outcome in cardiac surgery: a randomized trial.
Baysal A; Yanartas M; Dogukan M; Gundogus N; Kocak T; Koksal C
J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):586-94. PubMed ID: 24447501
[TBL] [Abstract][Full Text] [Related]
15. Prophylactic levosimendan for the prevention of low cardiac output syndrome and mortality in paediatric patients undergoing surgery for congenital heart disease.
Hummel J; Rücker G; Stiller B
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011312. PubMed ID: 28770972
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
Kolseth SM; Nordhaug DO; Stenseth R; Sellevold O; Kirkeby-Garstad I; Wahba A
Eur J Cardiothorac Surg; 2009 Dec; 36(6):1024-30. PubMed ID: 19592266
[TBL] [Abstract][Full Text] [Related]
17. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
[TBL] [Abstract][Full Text] [Related]
18. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
Mehta RH; Leimberger JD; van Diepen S; Meza J; Wang A; Jankowich R; Harrison RW; Hay D; Fremes S; Duncan A; Soltesz EG; Luber J; Park S; Argenziano M; Murphy E; Marcel R; Kalavrouziotis D; Nagpal D; Bozinovski J; Toller W; Heringlake M; Goodman SG; Levy JH; Harrington RA; Anstrom KJ; Alexander JH;
N Engl J Med; 2017 May; 376(21):2032-2042. PubMed ID: 28316276
[TBL] [Abstract][Full Text] [Related]
19. Meta-analysis of randomized trials of effect of milrinone on mortality in cardiac surgery: an update.
Majure DT; Greco T; Greco M; Ponschab M; Biondi-Zoccai G; Zangrillo A; Landoni G
J Cardiothorac Vasc Anesth; 2013 Apr; 27(2):220-9. PubMed ID: 23063100
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design.
Zangrillo A; Alvaro G; Pisano A; Guarracino F; Lobreglio R; Bradic N; Lembo R; Gianni S; Calabrò MG; Likhvantsev V; Grigoryev E; Buscaglia G; Pala G; Auci E; Amantea B; Monaco F; De Vuono G; Corcione A; Galdieri N; Cariello C; Bove T; Fominskiy E; Auriemma S; Baiocchi M; Bianchi A; Frontini M; Paternoster G; Sangalli F; Wang CY; Zucchetti MC; Biondi-Zoccai G; Gemma M; Lipinski MJ; Lomivorotov VV; Landoni G
Am Heart J; 2016 Jul; 177():66-73. PubMed ID: 27297851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
